Previous Speakers

SIGMA

Date:   February 17, 2010
Time:   3:00 p.m. - 4:30 p.m.
Location: MISCL Seminar Room, Bldg 75, 3rd Floor 
 

Presentations:

Modulation of Gene Expression in Stem Cells Using RNA Interference
Supriya Shivakumar, Ph.D.

Therapeutic Applications of Zinc Finger Nuclease Technology
Philip Gregory, Ph.D.

Targeted Knockout Rats:
Implications for Drug Discovery and Development
Supriya Shivakumar, Ph.D.

About the Speakers:

Dr. Philip Gregory has served as Chief Scientific Officer and Vice President Research,
Sangamo Biosciences, since July 2009. He joined Sangamo in December 2000 as a Scientist,
became a Team Leader in October 2001, Senior Director, Research in July 2003 and Vice
President, Research in October 2005. Prior to joining the company, Dr. Gregory was at the
University of Munich, Germany, where he studied the role of chromatin structure in gene
regulation and published extensively in this field. Dr. Gregory earned a Ph.D. in Biochemistry
from the University of Oxford and holds a B.Sc. in microbiology from the University of Sheffield.

Dr. Supriya Shivakumar currently holds the position of Group Leader for the Functional
Genomics Initiative, Sigma-Aldrich, leading the commercialization and new product
development eff orts of the RNAi and Targeted Genome Editing group. She completed her
Ph.D. at UCSF, jointly conducting research in wnt signaling in mouse and in the genetic model
system of C. elegans in the laboratories of Nobel Laureate Dr. Harold Varmus and Dr. Cynthia
Kenyon at the University of California, San Francisco. Her postdoctoral work — studying human
papilloma viral E7 signaling in cervical cancer — took her closer to clinical applications of
cancer research at the Mount Zion Center for Translational Medicine in Northern California.
In business she has been a key member of startups BioProtocol, a life science protocol portal,
and BioStreet, a spin-off  of Burrill and Company in developing pharmaceutical mergers and
alliances.

Back to Listing